CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 106 enrolled
Drug / intervention
This is an observational study, no intervention is anticipated.other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06576856
NCT06576856N/ACompleted

Use of Salivary Markers to Heralding the Onset of Periodontal Disorders

Midwestern University·observational·Posted Aug 29, 2024·Updated Oct 16, 2025

In Brief

An observational study evaluating This is an observational study, no intervention is anticipated. for Periodontal Disease, Staging, Salivary Markers, Diagnosis. Completed, enrolled 106 participants across 1 site.

Detailed Summary

The swelling of the gum, or periodontitis, is the leading cause for tooth loss, and currently affects up to 65 million adults only in the United States. One of the reasons for the widespread of periodontitis is because currently there are no definitive methods to detect the onset of gum disease. This lack of foresight impedes medical professionals to enact any preventive measures before the disease already manifests itself. We wish to expand our understanding towards the development of periodontitis by studying the expression and activity of salivary markers that have been associated with advanced stages of the disease, wherein the supporting tissues of tooth (periodontium) are already irreversibly destroyed. We hypothesize that a progressive shift in the expression of such salivary markers can indicate a change or evolution of periodontitis staging. In specific, we seek to establish a quantifiable relationship among levels of salivary proteases called MMPs, level of metal ions in different stages varying from health to periodontitis. The overall goal of this proposal is to enhance the predictability of periodontitis, as we are currently unable to diagnose the disease until the manifestation of its clinical signs and symptoms.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedAug 29, 2024
Enrollment StartNov 6, 2021
Primary CompletionOct 10, 2023
Study CompletionOct 10, 2024
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 1.8 years ago

Interventions

This is an observational study, no intervention is anticipated.other

There is no intervention. This is an observational study.